Fibrocytes are collagen-type-I-producing cells that arise at low frequency from hematopoietic cells. We have analyzed in mice which leukocyte subsets are required for generation of fibrocytes and show that murine fibrocytes develop from the subpopulation of CD11b ؉ CD115 ؉ Gr1 ؉ monocytes under the control of CD4 ؉ T cells. In the absence of CD4 ؉ T cells, differentiation of fibrocytes was markedly reduced in vitro and in vivo. In the presence of CD4 ؉ T cells, the characteristics of T-cell activation critically determined development of fibrocytes. Polyclonal activation of CD4 ؉ T cells induced the release of soluble factors that completely prevented the outgrowth of fibrocytes and could be identified as IL-2, TNF, IFN-␥, and IL-4. Application of IL-2 and TNF significantly reduced the appearance of fibrocytes and the severity of fibrosis in the model of unilateral ureteral obstruction.
In contrast, activation of CD4 ؉ T cells in the presence of calcineurin inhibitors, but not mTOR inhibitors, markedly enhanced the outgrowth of fibrocytes and renal deposition of collagen I. Taken together, we show that differentiation of fibrocytes is critically dependent on CD4 ؉ T cells and that the context of T-cell activation determines whether development of fibrocytes is supported or blocked. Our data may have implications for prevention of organ fibrosis in autoimmune diseases and transplantation.
fibrosis ͉ transplantation ͉ kidney ͉ cytokines F ibrosis, defined as excess deposition of extracellular matrix, especially collagen type I, is often the result of incomplete healing after tissue destruction. In the kidney, three cell types have been described to develop into collagen-type-1-producing cells: resident mesenchymal cells (fibroblasts), epithelial or endothelial cells undergoing mesenchymal transformation, and collagen-Iproducing hematopoietic cells called fibrocytes (1) (2) (3) (4) . Fibroctyes were described by Bucala et al. (5) and arise under appropriate conditions at a low frequency from CD45 ϩ leukocytes. The bone marrow-derived fibrocyte precursors are present within the blood and attracted to sites of injury, where they differentiate into spindle-shaped fibrocytes and at least in part, mediate tissue repair and fibrosis. Fibrocytes have been described to develop with the help of CD4 ϩ T cells from peripheral blood monocytes (5) (6) (7) (8) (9) (10) . Fibrocytes express CD11b and chemokine receptors such as CCR7, CXCR4, and CCR2 (6, (11) (12) (13) that are involved in their recruitment to sites of inflammation and fibrosis (11) (12) (13) . Fibrocytes were detected in mouse models of pulmonary fibrosis, bronchial asthma, renal fibrosis, and skin wounds and in human interstitial pulmonary fibrosis, burns, and nephrogenic systemic fibrosis (6, 10, (12) (13) (14) (15) (16) (17) (18) . The contribution of fibrocytes to tissue fibrosis is still unclear. Early work in the model of bleomycin-induced pulmonary fibrosis suggested that fibrocytes constitute a major part of all collagen type I producing cells in the injured lung (12) . In the model of unilateral ureteral obstruction (UUO) blockade of CCR7 reduced the numbers of fibrocytes in the kidney and the degree of fibrosis (13) . However, there are also data challenging the contribution of fibrocytes to collagen production. In transgenic mice carrying a reporter gene under the control of the collagen promoter, no significant numbers of bone marrow-derived reporter gene-positive cells were found in the UUO model (19) . In a similar approach, bone marrow-derived reporter-gene-positive cells were found in the UUO model, but were considered to play only a minor role compared with intrinsic mesenchymal fibroblasts (20) . In bone marrow chimeric mice, not all leukocyte subpopulations may reconstitute with equal efficiency, and the reporter gene may only be expressed in a fraction of collagen-producing cells, thus resulting in underestimation of the number and diversity of collagenproducing cells.
CD4 ϩ T cells play a prominent role in the progression of fibrotic diseases. Studies conducted with cytokine-deficient mice have demonstrated that liver fibrosis is strongly linked to the development of a Th2 cell response involving IL-4, IL-5, IL-13, and IL-21 (21) (22) (23) (24) (25) (26) . Some of these factors also affect the development of fibrocytes. IL-4 and IL-13 promote, whereas IFN-␥ and IL-12 block differentiation of fibrocytes from their progenitors (27) . In addition, TGF-␤ was shown to promote the differentiation and accumulation of fibrocytes (6, 12) whereas aggregated IgG or serum amyloid P block differentiation (28, 29) . TNF can have pro-and anti-fibrotic effects (30) and, as a single agent, did not alter the numbers of human fibrocytes or their production of collagen I (8, 27) . Production of cytokines by CD4 ϩ T cells is regulated by the influx of Ca that interacts with calcineurin. The calcineurininhibitor cyclosporine A blocks the transcription of cytokines such as IL-2 and is associated with a number of toxic effects, most notably tubulointerstitial fibrosis in transplanted kidneys (31) (32) (33) (34) .
The precise origin of fibrocyte progenitors is unknown, and only few factors leading to increased or decreased differentiation are known. Using murine cells and the model of UUO that leads to a pronounced renal fibrosis, we analyzed in more detail which cells constitute the precursors of fibrocytes and which factors determine their differentiation into mature fibrocytes. Because T-cell-derived cytokines and cyclosporine A are associated with fibrosis, we investigated how T-cell activation in the absence or presence of immunosuppressive drugs and cytokines produced under these conditions influence the differentiation of fibrocytes.
properties in flow cytometry (Fig. 1C) . Large cells located within gate R1 showed a homogenous expression of collagen type I by intracellular fluorescence-activated cell sorting (FACS) staining ( Fig. 1D ) whereas small cells outside gate R1 had similar light scatter properties as freshly prepared splenocytes or peripheral blood cells and did not express collagen I (Fig. S1 and S2 ). FACS-analysis also clearly showed that these collagen I ϩ cells strongly express the pan-leukocyte marker CD45, a typical feature of fibrocytes (5) . In addition, collagen I ϩ CD45 ϩ cells showed a clear expression of CD16/32 and CD11b, a weak expression of MHC-II, but no expression of CD115, CD34, or CXCR4 (Fig. S2) . Using microscopy, the number of spindle-shaped cells was markedly reduced after in vitro depletion of cells expressing the monocyte markers CD16/32, CD11b, CD115, or Gr1 (Fig. 1B) . Total splenocytes or sham-depleted cell populations served as control. Depletion of CD11c ϩ dendritic cells (Fig. 1B) had no influence on the outgrowth of fibrocytes. CD115 is a rather specific marker for murine monocytes, and Gr1 is expressed on a subpopulation of monocytes that preferentially accumulate in inflamed tissues. Light scatter analysis and intracellular staining of collagen I confirmed that depletion of CD11b ϩ or CD115 ϩ cells, but not CD11c ϩ cells, almost completely prevents the outgrowth of fibrocytes ( Fig. 1 C  and D) . Quantification of collagen I in total cell lysates by ELISA verified that the overall amount of collagen I in culture significantly decreases after depletion of CD11b ϩ cells (Fig. 1E) . These results suggest that murine fibrocytes differentiate from a Gr1 ϩ monocyte subpopulation.
Conditions Supporting the Differentiation of Monocytes into Fibrocytes.

CD11b
ϩ or CD16/32 ϩ cells isolated from the spleen were used to study in more detail the conditions for differentiation of monocytes into fibrocytes. Addition of purified nonstimulated CD4 ϩ T cells markedly increased the differentiation of monocytes into spindleshaped fibrocytes ( Fig. 2A) . These data are consistent with the observation that depletion of CD4 ϩ T cells from total splenocytes almost completely prevented the outgrowth of fibrocytes (Fig. 1B) . To further investigate the influence of factors derived from CD4 ϩ T cells on the differentiation of fibrocytes, we cultured purified monocytes with the supernatant of CD4 ϩ T cells. If CD4 ϩ T cells were polyclonally activated for 72 h in the presence of cyclosporine A, the supernatant of these cells (SN CyA) markedly increased the ability of monocytes to develop into fibrocytes during a 14-day culture. This became evident by increased numbers of spindleshaped cells (Fig. 2 A) , by increased levels of collagen I in the cell lysate (Fig. 2B) , by increased secretion and deposition of collagen I on the culture plate (Fig. 2C) , and by an up-regulation of collagen I mRNA measured by real-time PCR (Fig. 2D ). If CD11b ϩ monocytes were exposed to SN CyA, we also found increased numbers of collagen I ϩ CD45 ϩ fibrocytes with typical light scatter properties by flow cytometry ( Fig. 2 E and F) . To investigate whether cyclosporine A promotes the generation of fibrocytes by acting on CD4 ϩ T cells and changing their production of soluble mediators or by directly acting on CD11b ϩ monocytes, we incubated purified CD11b ϩ monocytes either with SN CyA or with medium containing the same concentration of cyclosporine A (Fig.  2G ). SN CyA significantly increased the development of fibrocytes whereas cyclosporine A alone had no effect. We also analyzed the calcineurin inhibitor (tacrolimus) and the mTor inhibitor rapamycin. The supernatant of CD4 ϩ T cells activated in the presence of tacrolimus (SN TAC) increased whereas the supernatant of CD4 ϩ T cells activated in the presence of rapamycin (SN Rapa) decreased the development of fibrocytes and the deposition of collagen I. SN CyA heated to 95°C did not enhance generation of fibrocytes, indicating that the T-cell-derived factors may consist of soluble proteins (Fig. 2H ). TGF-␤ appeared as possible candidate, because cyclosporine A induces the expression of TGF-␤ from CD4 ϩ T cells (35, 36) and TGF-␤ is known to support the generation of fibrocytes (6, 15) . Blockade of TGF-␤ with an antibody partially reduced the differentiation of monocytes into fibrocytes in the presence of SN CyA whereas it had no effect in the absence of SN CyA (Fig. 2I) . To demonstrate more directly that Gr1 ϩ monocytes have the ability to differentiate into collagen-producing fibrocytes, CD11b ϩ Gr1 ϩ and CD115
ϩ Gr1 ϩ monocytes were highly purified by FACS sort (purity Ͼ97%) (Fig. S3) . If the purified monocytes were cultured in plain medium, no fibrocytes developed. However, when the cells were cultured in the presence of SN CyA numerous large spindleshaped cells developed that secreted collagen I as measured by ELISA and displayed typical light scatter properties in flow cytometry (Fig. S3 ). In contrast, CD115
ϩ Gr1 Ϫ monocytes did not develop into fibrocytes, even in the presence of SN CyA. These results demonstrate that Gr1 ϩ monocytes are dependent on additional factors for differentiation into fibrocytes. suppressive drugs (SN) completely prevented the differentiation of monocytes into spindle-shaped fibrocytes (Fig. 3A) . This was confirmed by flow cytometry, where the large fibrocytes completely disappeared in light scatter plots, and collagen I ϩ cells were absent (Fig. 3B) . We used blocking antibodies against several T-cellderived cytokines to elucidate which cytokines suppress the development of fibrocytes. Combined blockade of four cytokines (IL-2, IL-4, TNF, and IFN-␥) was required to restore the generation of spindle-shaped fibrocytes (Fig. 3C) . Blockade of only two or three of these factors (IL-2, TNF, and IFN-␥) had no or only minor effects. CD4 ϩ T cells activated with anti-CD3 released substantial amounts of IFN-␥, TNF, IL-4, and IL-2, which was almost completely prevented by cyclosporine A or tacrolimus, whereas rapamycin had an intermediate effect (Fig. S4) .
To analyze the suppressive effects of these cytokines more directly, we quantified the differentiation of monocytes into fibrocytes in the presence of various cytokines. Application of single cytokines showed, that IFN-␥, IL-2, and TNF suppress the generation of spindle-shaped fibrocytes. The combinations of IL-2 ϩ TNF, IL-2 ϩ IL-4, and IL-2 ϩ IFN-␥ were most potent and also significantly suppressed the deposition of collagen I (Fig. 3D) . All tested combinations of three cytokines almost completely suppressed the appearance of fibrocytes and the deposition of collagen I (Fig. S5 ).
IL-2 and TNF Reduce the Numbers of Fibrocytes and the Amount of Renal
Fibrosis in Vivo. To analyze the generation of fibrocytes in vivo, we used the model of UUO in mice. After UUO, a hydronephrosis with progressive deposition of extracellular matrix in the cortex and accumulation of collagen-producing cells occurs (37) (38) (39) . On day 7 after UUO CD45 ϩ , collagen I ϩ fibrocytes were identified in the kidneys and spleen by flow cytometry. Staining with an isotype control antibody confirmed the specificity of the intracellular staining for collagen I (Fig. 4A) . UUO kidneys contained significantly more CD45 ϩ collagen I ϩ cells than the contralateral kidneys or the spleens (Fig. 4B) . Because of the widespread deposition of collagen I in UUO kidneys, we were unable to clearly identify CD45 ϩ collagen I ϩ cells by immunohistology with double staining for CD45 and collagen I. To further demonstrate that CD45 ϩ cells express collagen I in the UUO kidney, we performed unilateral ureteral ligation in rats, highly purified CD45 ϩ cells from the kidneys and spleens by FACS sorting (Fig. 4C) , and quantified the amount of collagen I mRNA by real-time RT-PCR. CD45 ϩ cells isolated from the obstructed kidneys expressed significantly more collagen I mRNA than CD45 ϩ cells isolated from the contralateral kidneys or the spleens (Fig. 4D) . These data indicate that fibrocytes are present in the obstructed kidney and can reliably be identified by flow cytometry.
Mice were treated from days 0 to 6 after UUO with IL-2 and TNF or PBS as control. The frequency of fibrocytes was determined by flow cytometry in both kidneys and the spleen (Fig. 5 A and B) , and the expression of collagen I mRNA was quantified by RT-PCR (Fig. 5C ). In addition, deposition of collagen I in the obstructed kidneys was quantified by immunofluorescence (Fig. 5D) and Western blot analysis (Fig. 5E ) using quantitative readouts as described in the Materials and Methods section. Treatment of mice with IL-2 and TNF resulted in a significant reduction of the numbers of fibrocytes, collagen I mRNA expression, and deposition of collagen I in the obstructed kidneys. In the contralateral kidneys or the spleens, the numbers of fibrocytes or mRNA expression of collagen I were not significantly altered by IL-2 and TNF. Treatment with IL-2 and TNF did not change the total number of infiltrating CD45 ϩ cells in the kidneys and did not alter the number of apoptotic cells per high power field (hpf) in UUO kidney sections (Fig. S6) . by the presence of nonactivated CD4 ϩ T cells (Fig. 2 A) . To investigate the influence of CD4 ϩ T cells in vivo, we induced UUO in T-cell-deficient SCID mice on a BALB/c background and quantified the number of infiltrating CD45 ϩ collagen I ϩ fibrocytes in both kidneys by flow cytometry (Fig. 5F ). We found that the number of fibrocytes in the UUO kidneys of SCID mice was significantly lower than in wild-type BALB/c mice and that deposition of collagen was significantly reduced in SCID mice (Fig. S7A) . The number of apoptotic cells per hpf was identical in UUO kidney sections of BALB/c and SCID mice (Fig. S7B) .
We also used antibody-mediated depletion of CD4 ϩ T cells as a second approach (Fig. S8) . In the absence of CD4 ϩ T cells, the numbers of CD45 ϩ collagen I ϩ fibrocytes and the deposition of collagen I was significantly reduced in UUO kidneys (Fig. S8 B and  E) . The total number of infiltrating CD45 ϩ leukocytes in the kidneys and the number of apoptotic cells per hpf in sections of UUO kidneys were not altered (Fig. S8 C and D) . These data indicate that CD4 ϩ T cells play an important role for differentiation of fibrocytes in vivo.
Influence of Cyclosporine A and Rapamycin on Fibrocytes and Renal
Fibrosis in Vivo. As described above, T-cell activation in the presence of cyclosporine A markedly enhanced the generation of fibrocytes in vitro. To confirm these results in vivo, UUO-treated mice were injected daily with anti-CD3 antibody for polyclonal activation of T cells and simultaneously treated with cyclosporine A, rapamycin, or olive oil as control. Flow cytometry demonstrated that the number of CD45 ϩ CD11b ϩ collagen I ϩ fibrocytes in the UUO kidneys of mice treated with cyclosporine A was significantly increased compared with the vehicle control (Fig. 5G) . Treatment with cyclosporine A also significantly increased the level of collagen I mRNA (Fig. 5H ) and the severity of fibrosis (Fig. 5I) in the obstructed kidneys. Treatment of mice with rapamycin did not alter the number of fibrocytes or the expression of collagen I. Treatment with cyclosporine A or rapamycin did not significantly change the number of infiltrating CD45 ϩ leukocytes in UUO kidneys and the number of apoptotic cells per hpf in UUO kidney sections (Fig. S9) .
Discussion
The cellular origin of fibrocytes and conditions enhancing or decreasing the development of fibrocytes have mostly been analyzed in vitro with human cells. Only few data are available on differentiation of fibrocytes in vivo. We have studied in mice, which cells have the ability to differentiate into fibrocytes, and how this differentiation is regulated. We have used several complementary methods (light microscopy, flow cytometry, RT-PCR, and ELISA) to identify fibrocytes and to confirm expression of collagen I. Flow cytometry with extracellular staining of CD45 and intracellular staining of collagen I proved to be a very reliable method to identify fibrocytes in single-cell suspensions of kidneys. A clear intracellular staining for collagen I was detectable in a distinct subpopulation of 
CD45
ϩ cells in the UUO kidneys but at a much lower frequency in the contralateral kidneys and the spleens. Highly purified CD45 ϩ cells from fibrotic kidneys expressed significantly higher levels of collagen I mRNA than CD45 ϩ cells from the spleens or contralateral kidneys.
Using cell depletion experiments and purified cells, we show that CD11b ϩ CD115 ϩ Gr1 ϩ monocytes are the precursor cells of fibrocytes in mice. Gr1 ϩ monocytes did not spontaneously differentiate into fibrocytes in vitro, but required supporting factors (either CD4 ϩ T cells or factors derived from them). We observed some variation in the differentiation of enriched CD11b ϩ monocytes into fibrocytes, which may result from the use of individual mice or the presence of cells that remained after enrichment of monocytes. A supportive role of CD4 ϩ T cells for differentiation of fibrocytes has been described with human cells (6) . Also in the mouse, depletion of CD4 ϩ T cells almost completely prevented the development of fibrocytes from spleen cells, whereas coculture of purified monocytes with nonactivated CD4 ϩ T cells markedly enhanced the outgrowth of fibrocytes. The presence of CD4 ϩ T cells also increased the number of fibrocytes in the UUO model as demonstrated with T-cell-deficient SCID mice and by antibodymediated depletion of CD4 ϩ T cells.
The supernatant of activated CD4 ϩ T cells had a pronounced influence on fibrocytes. Polyclonal T-cell activation in the absence of calcineurin inhibitors resulted in the release of soluble factors that completely prevented the differentiation of monocytes into fibrocytes whereas T-cell activation in the presence of calcineurin inhibitors had the opposite effect. We have identified the inhibitory factors (IL-2, IL-4, TNF, and IFN-␥) using a large panel of monoclonal antibodies against T-cell-derived cytokines. Similarly, addition of recombinant cytokines, especially the combination of IL-2 and TNF almost completely blocked the outgrowth of fibrocytes. Some differences exist between humans and mice, as IL-4 enhanced fibrocyte differentiation in humans (27) , whereas it had an inhibitory effect in mice. IL-13 enhanced collagen I production in the mouse and in humans. In the model of UUO, application of IL-2 and TNF markedly reduced the number of fibrocytes and the overall amount of fibrosis in the obstructed kidneys, indicating that IL-2 and TNF also regulate the development of fibrocytes in vivo. The correlation between the number of infiltrating fibrocytes and the degree of fibrosis suggests that fibrocytes contribute to renal fibrosis in this model, although we cannot exclude that IL-2 and TNF also affect other collagen-producing cells. Release of proinflammatory cytokines during an acute immune response, may contribute to restitution without appearance of fibrosis.
Prolonged subacute activation of T cells or T-cell activation in the presence of calcineurin inhibitors is associated with the development of fibrosis. Long-term use of calcineurin inhibitors and episodes of transplant rejection enhance the risk of chronic allograft dysfunction and fibrosis in patients after kidney transplantation (31, 40, 41) . In contrast, rapamycin seems to induce less or no renal fibrosis (42) . Cyclosporine A, but not rapamycin, increased the development of fibrocytes and the severity of fibrosis in UUO model. We assume that T-cell activation in the presence of cyclosporine A increases the release of profibrocytic factors (e.g., TGF-␤) and decreases the release of antifibrocytic cytokines. 
